1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow iratumumab: new trials by email Literature Review of iratumumab trials Research Report on iratumumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma iratumumab - Lymphoma | Phase 1 / Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 2003-01-01 | 2013-05-30 |
Dendritic Cell Sarcoma, Interdigitating (1) · Hodgkin Disease (1) · Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, T-Cell, Cutaneous (1) · Recurrence (1)
Memorial Sloan Kettering Cancer Center (1)
United States (1)